UPCC 36125 A survey on current treatment and surveillance practices in MBC

Enrolling By Invitation
99 years or below
All
Phase N/A
1 Location

Brief description of study

Male breast cancer (MBC) is rare, comprising only 1% of all breast malignancies. Due to lack of clinical trial data, treatment of MBC is largely extrapolated from current guidelines on management of female breast cancer (FBC). This study aims to investigate current treatment patterns in MBC. An anonymous online survey will be sent via Society of Surgical Oncology (SSO) to practicing surgeons across the United States and worldwide.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 02 Sep 2026. Study ID: 25-2199
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator